The Bioavailable Watchlist

An investigational incretin-pathway drug with strong obesity signals and a late-stage trial program, but no approved use yet.

Key unknown: Longer-term benefit-risk, discontinuation patterns, lean-mass effects, cardiovascular and renal outcomes, and whether sponsor-reported late-stage results replicate in full peer-reviewed data.

A myostatin-pathway antibody being studied as an adjunct to obesity treatment, with sponsor-released interim signals that need peer-reviewed confirmation.

Key unknown: Whether body-composition changes translate into strength, mobility, long-term function, and acceptable safety.

An approved GLP-1 receptor agonist with extensive clinical data in diabetes, obesity, and selected cardiovascular-risk contexts.

Key unknown: How to interpret long-term population use, discontinuation, access, rare risks, and broader claims outside studied contexts.

An approved incretin-pathway medicine with strong obesity and diabetes evidence and expanding indication-specific use.

Key unknown: Long-term real-world outcomes, discontinuation, tolerability, access, and claims beyond studied populations.

Topical skin and wound-healing contexts have more plausible evidence than broad systemic longevity claims.

Key unknown: Whether product form, purity, delivery context, and endpoint choice materially change risk and benefit.

Heavy internet interest, mostly preclinical musculoskeletal and wound-healing narratives, and an important regulatory/product-identity boundary.

Key unknown: Human efficacy, long-term safety, product identity, immunogenicity, and whether marketed products resemble studied material.

A major identity problem: studied thymosin beta-4 contexts are not the same as broad internet TB-500 recovery claims.

Key unknown: Product identity, human outcome evidence for the claimed use, safety, and whether studied formulations map to marketed peptides.

A mitochondria-derived peptide with mechanistic metabolic interest and limited human outcome evidence.

Key unknown: Clinical outcomes, safety, product identity, and whether biomarker movement would mean anything patients can feel or measure clinically.

A telomerase and aging-claim peptide where mechanistic narratives outrun independently replicated human outcome evidence.

Key unknown: Replication quality, endpoint validity, long-term safety, and product identity.

An approved medicine for a specific HIV-associated lipodystrophy context, often overgeneralized into broader body-composition claims.

Key unknown: Whether off-label body-composition narratives have clinically meaningful outcome evidence in different populations.

Early endocrine signals exist, but internet claims often jump from hormone biomarkers to anti-aging, recovery, or body-composition outcomes.

Key unknown: Long-term safety, cancer and cardiometabolic tradeoffs, product identity, and whether claimed outcomes are clinically demonstrated.

An obesity-claim peptide fragment with old clinical development signals, limited modern clinical relevance, and regulatory caution.

Key unknown: Clinical relevance, product identity, and whether claimed outcomes persist under controlled conditions.

A small anti-inflammatory peptide with mechanistic gut and inflammation interest, but no strong human outcome base.

Key unknown: Human efficacy, safety, product identity, and which indication would be plausible enough to test.

An antimicrobial peptide with specific wound and immune-biology research, but safety and formulation questions make broad use claims risky.

Key unknown: Therapeutic window, formulation, indication, route-specific safety, and whether benefits survive serum and tissue complexity.

An approved drug in specific medical contexts and a central longevity research compound, but human anti-aging claims remain unsettled.

Key unknown: Net benefit in otherwise healthy people, immune and metabolic tradeoffs, cancer-context complexity, and validated aging endpoints.

Human studies show NAD-biomarker movement, while durable clinical-outcome claims remain much less certain.

Key unknown: Which populations benefit, which endpoints matter, long-term safety, and whether biomarker changes translate into outcomes.

A noninvasive neuromodulation modality with FDA-cleared device contexts and ongoing optimization questions.

Key unknown: Response prediction, durability, targeting optimization, and the boundary between cleared use and experimental settings.

A structured investigational therapy model with randomized depression data, but no broad approval and major implementation questions.

Key unknown: Durability, rare harms, therapist/support infrastructure, patient selection, regulatory requirements, and real-world generalizability.

An addiction-treatment research compound with high public interest and unusually important cardiac safety concerns.

Key unknown: Whether a regulated clinical pathway can separate any therapeutic signal from unacceptable acute risk.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.

Queued for structured source review. Inclusion means the claim is being tracked, not endorsed.

Key unknown: The evidence level, product identity, regulatory status, and claim scope require source review.